Drawing for JARI

USPTO serial 79239627

JARI

Reviewed by CopyMark Law Group

Reg. 5809220Status 404
Filing date
Status date
Registration date
Jul 23, 2019
Examiner
JOHNSON, AISHA CLARKE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with JARI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Chemical preparations for medical or veterinary purposes for the prevention and treatment of cancer; balsamic preparations for medical purposes for the prevention and treatment of cancer; medicines for alleviating constipation; digestives for pharmaceutical purposes; laxative; ointments for pharmaceutical purposes for the prevention and treatment of cancer; tranquillizers; sedatives; soporific; biological preparations for medical purposes for the prevention and treatment of cancer; chemical preparations for medical purposes for the prevention and treatment of cancer; enzymes for medical purposes; pharmaceutical preparations in the form of injection, tablet, aqueous formulation, tincture, capsule, ointment, for the prevention and treatment of cancer, for the treatment of cardiovascular and cardiopulmonary disorders, prevention and treatment of disorders of the nervous system, the immune system, the metabolic system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders; radiological contrast substances for medical purposes; diagnostic preparations for medical purposes; anti-epileptic pharmaceutical preparations; anti-cancer preparationsSECTION 71 - CANCELLED—
042Technical research in the field of pharmaceutical studies; technical project studies, in the field of pharmaceutical studies; scientific laboratory services; oil-well testing; geological prospecting; oil prospecting; computer programming; computer software design; consultancy in the design and development of computer hardware; maintenance of computer software; computer system analysis; computer system design; conversion of computer programs and data, other than physical conversion; monitoring of computer systems by remote access to ensure proper functioning; engineering; Providing quality checking and testing of products; Providing quality checking and testing of products in the field of engineering; Providing quality assessment services in the field of product engineering; quality control services for certification purposes in the field of engineering; updating of computer software; rental of computer software; recovery of computer data; creating and maintaining web sites for others; web site hosting services; installation of computer software; computer software consultancySECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 12, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 6, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 6, 2026C71TCANCELLED SECTION 71—
Dec 6, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 18, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 18, 2019FIMPFINAL DISPOSITION PROCESSED—
Oct 23, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 23, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 31, 2019GPNXNOTIFICATION PROCESSED BY IB—
May 7, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 17, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 17, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 17, 2019NPUBNOTICE OF PUBLICATION—
Mar 25, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 22, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 22, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 22, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 21, 2018RFNPREFUSAL PROCESSED BY IB—
Nov 23, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 23, 2018RFRRREFUSAL PROCESSED BY MPU—
Nov 9, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 8, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 27, 2018DOCKASSIGNED TO EXAMINER—
Sep 11, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 7, 2018FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 5, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 4, 2018LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Aug 23, 2018SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance